The Indian government is addressing concerns related to high trade margins on cancer medications. Pharmaceutical Secretary Manoj Joshi highlighted unethical practices occurring within the healthcare industry. He noted that hospitals often prefer expensive medicines that provide higher margins.
Source: [Times of India](https://timesofindia.indiatimes.com/india/steep-margins-allow-room-for-malpractice-pharmaceuticals-secretary/articleshow/134803150.cms)